A Phase I, double-blinded, randomized, placebo-controlled ascending IV single-dose study assessing the safety, tolerance, and pharmacokinetics of Neu2000 in healthy volunteers.

Authors
Category Primary study
JournalStroke
Year 2009
This article has no abstract
Epistemonikos ID: 1cc0046f92ccd5302eed3f3c0369dbdd9651392e
First added on: Feb 28, 2025